Kimby E, Axelsson B, Björkholm M, Gordon J, Holm G, Mellstedt H
Med Oncol Tumor Pharmacother. 1985;2(4):261-7. doi: 10.1007/BF02934912.
The study consists of 6 CLL patients with leukemic blood lymphocytes lacking T-cell characteristics and with smIg on only a very small fraction of the cells detected by microscopy or FACS analysis after direct immunofluorescence (IFL) staining. Using B-cell specific monoclonal antibodies all leukemias were found to be of the B-cell type. SmIg, mainly of IgD-class and the monotypic light chain, was detected on a large number of cells in all cases when using direct IFL. No lymphocyte clone was judged to be of the pre-B-cell type or represented fully differentiated terminal B-cells. CLL cells from the individual cases probably represent intermediate B-cell maturation steps. The results lend no support to the suggestion that this subtype of CLL necessarily belongs to an early stage of differentiation just beyond the pre-B-cell level.
该研究包括6例慢性淋巴细胞白血病(CLL)患者,其白血病血淋巴细胞缺乏T细胞特征,并且在直接免疫荧光(IFL)染色后,通过显微镜检查或荧光激活细胞分选(FACS)分析,仅在极小部分细胞上检测到表面膜免疫球蛋白(smIg)。使用B细胞特异性单克隆抗体,发现所有白血病均为B细胞类型。当使用直接IFL时,在所有病例的大量细胞上均检测到主要为IgD类和单型轻链的smIg。没有淋巴细胞克隆被判定为前B细胞类型或代表完全分化的终末B细胞。个别病例的CLL细胞可能代表B细胞成熟的中间阶段。这些结果不支持关于这种CLL亚型必然属于前B细胞水平之后的早期分化阶段的观点。